Investing Billions - E303: What Blackjack Taught Me About Investing w/Ari Levy
Episode Date: February 12, 2026Where does real edge still exist in public markets and how do you size risk when certainty doesn’t exist? In this episode, I talk with Ari Levy, Founder and CIO of Lakeview Investment Group, about ...applying probability theory, arbitrage, and disciplined position sizing to public equity investing. Ari explains how early lessons from card counting and game theory shaped his approach to risk, why small-cap markets remain structurally inefficient, and how activism, arbitrage, and management access can create asymmetric outcomes—without blowing up the portfolio.
Transcript
Discussion (0)
You've said that probability theory was your first love.
What made you love probabilities from an early age?
Sports statistics, I would say, number one.
Like to simulate baseball seasons when I was really little on the Apple 2E computer
on a very early video game that didn't, you know,
was pretty much mostly statistics and not actually like interacting in the game
as like a batterer or pitcher, but just hitting SB if you're trying to steal a base.
but I would simulate baseball seasons between, you know,
you could have the 1927 Yankees play the 1955 Giants
and have Willie Mays play against Babe Ruth.
And so I was like just love that concept
and trying to think about advanced statistics at a young age
and just games of strategy, played a lot of cards,
try to figure out how to win things.
They good risk-adjusted, asymmetric, calculated bets, effectively.
And you ran a blackjack team when you were,
were at Stanford, what did you learn about that? And how does that relate to how you do public
investing today? I took a course my freshman year at Stanford, this was in 1997, called Math in Sports.
That was my favorite class I ever took. Professor Tom Cover at Stanford taught this freshman
seminar, small group of 15 like-minded folks just thinking about this same kind of, you know,
game theory, probability theory in both sports, which,
was the name of the class, but also the deck of cards.
And Professor Kover had had his own blackjack team in the 70s and just great stories.
Fascinating statistics professor and a couple of us from the class, I fred Brad Griffith,
who founded Game Time, which is ticketing, the online ticketing platform.
And I just took a real liking to it.
We were already friends who lived in the same freshman dorm and constantly were quizzing each
other on the blackjack statistics.
And so we just got excited about how we could optimize that.
that game. And in, in cards, there's a known quantity, known set of, you know, there's four suits
and 13 cards in each suit and all the rules that we all know. And so it's, it's much more of a
fixed probability in the stock market. They call it, you know, stock is more of a random walk.
So it's a whole different distribution. There's no, history doesn't repeat itself exactly,
but like the Mark Twain quote, history doesn't repeat itself, but it rhymes. There's, you know,
a lot of historical analysis to help figure.
out what the future might hold to make educated, risk adjusted. There's some principles from
the things I learned in card counting, specifically something called the Kelly Criterion,
which is like a theoretical proof of for a known set of odds. Again, with cards having a known
set of odds, it tells you how much to risk on any given wager such that you're maximizing
your profit while also not putting your balance sheet at a big,
It's called risk of ruin.
Most famously, long-term capital management had what they believe, this risk-free arbitrage,
and they hadn't thought about all the second-order effects of it,
and ultimately the fund blew up because of Russia and the divergence in pricing.
How do you go about looking at your risk and assessing where your trade might go wrong?
That is a really good point, and something that we all think about if you're a smart investor.
You can't believe that it's going to, like what I said, with certainty, there are still, you know, events, idiosyncratic things that could happen.
One that I can think of, for example, and this is more of a microlevel versus like long-term capitals model.
Multiple second order events happened.
I believe that, you know, with plus some leverage, leverage is always an important factor.
But for example, in the volatility space, VXX is the largest ETF.
It owns a combination of front and second month futures on voluminous.
volatility, almost in the entirety of its history, you could create and redeem it, which, as I was
saying before, keeps the ETFs in line. So VXX, if you just look on a Bloomberg machine at any
given time, typically isn't below 10 basis point discount or above a 10 basis point premium.
And, you know, they charge a fee to create and redeem it. And so it's not, it's not,
there's another cost. But that's what keeps in a line. So if you could buy that at a 50 basis point
discount and redeem it that day, you'd make 50 basis points in that day. And that would be
obviously credible. If you spread it to something that was trading it now.
Now, in this example, I'm talking about a sort of idiosyncratic risk where the underwriters of VXX, this happened a few years ago, had not properly registered new share issuances with the SEC.
No one could effectively know that, I guess, unless you're a super smart lawyer and could figure out that they hadn't registered something correctly.
And so what happened was they could not issue new shares.
You couldn't create redeem.
and there was effectively like a squeeze on it,
where it traded at a 20% premium
for an extended period of time
until they resolved their SEC issues.
And so that mechanism went away.
So if you have this rule that you can create redeem
and that's going to keep it at NAV,
well, what else could go wrong?
That was an example of something
that was kind of out of left field.
There's however many thousands of ETFs out there
that do it right with the SEC
and the XX underwriters eventually got
back in line and now it trades in line, but could that happen again, something like that in the case
of long-term capital? Yeah, could there be, you know, sovereign risk or whatever you're trading
that things come out of left field. You think you're trading something that is the same as some other
thing, but the underwriter of one of those things had fraud, and they were buying something else.
We've, you know, we've seen that in different cases throughout history. There's the MF Global,
which was a perfect arb there, but that you thought you were buying something that was
something else and someone was going rogue with the investment that you made and you got to be
really careful about that. And the catch-all solution for that risk management is position sizing.
So even if it's even if it blows up and even if you have 10%, maybe you lose two, three percent.
So you don't have to know how it'll blow up to size it correctly and to keep your entire
portfolio from getting ruined. One of the hardest things of investing is seeing what's shifting
before everyone else does. For decades, only the largest hedge funds could afford extensive channel
research programs to spot inflection points before earnings and to stay ahead of consensus.
Meanwhile, smaller funds have been forced to cobble together ad hoc channel intelligence
or rely on stale reports from sell-side shops. But channel checks are no longer a luxury.
They're becoming table stakes for the industry. The challenges has always been scale, speed,
and consistency. That's where AlphaSense comes in. AlphaSense is redefining channel research instead of
static point in time reports, Alpha Sense channel checks delivers a continuously refreshed view
of demand, pricing, and competitive dynamics powered by interviews with real operators,
suppliers, distributors, and channel partners across the value chain.
Thousands of consistent channel conversations every month deliver clean, comparable signals,
helping investors spot inflection points weeks before they show up in earnings or consensus
estimates.
The best part, these proprietary channel checks integrate directly into AlphaSense's research
platform trusted by 75% of the world's top hedge funds with access to over 500 million premium
sources from company filings and brokerage research to news, trade journals and more than 240,000
expert call transcripts. That context turns raw signal into conviction. The first to see wins,
the rest follow. Check it out for yourself at alpha dash sense.com slash how I invest.
Yes. So you have to cap the size of the exposure you have to any one individual.
The only risk to the overall portfolio is if you're making the same trade over and over that has the same underlying catalyst that drags it down.
Yes, if they all, or multiple of your spreads or trades or investments, whatever you want to call it, have some similar idiosyncratic risk that hits them all at the same time or multiple of them, then, you know, if you lose 2% on multiple different 10% trades, obviously it adds up to more than 2%.
Last time we chatted, you said that 5,000 to 10,000 small cap.
companies are inefficiently priced. Tell me about that and what are the opportunities there.
So I don't know how many small cap stocks exactly there are. I know there's thousands and it depends
if you look globally or in the U.S. They tend to be less efficiently priced than large cap stocks
because there's informational inefficiency. In the large cap stock world, you see a lot more analyst
coverage. So many more people have read Apple's filings. However many multiple,
versus some little nichey company in a industry you didn't even know existed
or weren't thinking about that that's a $500 million market cap versus a trillion dollar market
cap.
And over time, we've seen that kind of spread diverge.
We've had we've had a decade, for example, where large cap, decade and a half,
where large cap has just crushed small cap.
There are different reasons for that.
There's been much more of a regulatory burden on small cap companies where a public
company typically needs to spend five plus million dollars to be public. It's obviously more for the larger
companies, but as a percentage of their size and their profit and cash flow for the small companies,
it hurts a lot more. And so if the, at the Sarbanes Oxley and other other costs make it just
difficult, you know, there are companies that we own that. I'd do 20 million of free cash flow a year.
Well, if they were private, they would, they would do 25 million because they didn't have to spend
that $5 million to do that. I can tell you from being on the board of a public company, which was
Del Taco, a small cap stock. We probably spent a third of our board meetings just talking about
things that had nothing to do with other than regulatory Sarbanes-Oxley and compliance costs that
just add up to much more meaningful amount for a small company as a percentage than a large company.
And with index funds just going larger and larger, there's been a huge increase in assets going
from active to passive. Honestly, throughout my been in the public markets for 25 years. Of course,
there was the S&P 500, but the whole time and the Russell,
that I've been in business, but the increase in just number of passive funds is now, I believe,
over half of the market. And with that, there is, most of it is in the major that we look today,
for example, the S&P 500 versus the S&P 600, which is their small cap index, has what is
known to be 17 times the amount of dollar assets in the SVB 500. It's actually way more than that
if you factor in all the private funds and indexing or even like quasi index funds,
they might say they're somewhat active.
But they,
but they're index huggers,
we call instead of having a 7% position in VDia,
they've got a 6% position or something that still makes them look a lot like the S&D 500 or
or the NASDAQ 100 or whatever.
And the small cap companies just get much less efficiently priced.
So,
you know,
you roll up your sleeves and you,
you look at some niche industry, some niche business that you think is asymmetric, well,
you're going to get much better access to management.
You're going to be able to talk to the CEO and CFO of the company versus trying to do that
with Apple.
Good luck.
You've got to be a, you know, $300 billion mutual fund company or something to get that.
And how do you marry those strategies of meeting management and trying to get a better read
on management versus kind of these arbitrage opportunities that are basically.
basically in the spreadsheets or in the trade versus kind of this, this EQ level inside.
My first love, my favorite are the more arbitrage trades. If you, if you could give me only
trades that make five basis points a day instead of, again, the one basis point that the,
that the government's offering you. It's hard to make that that adds up to, let's say, 18% of
your return that it's hard to get some in 18% your return compounded in picking stocks. There's more
risk. And so I would take that all day long. But finding those things that pay you five
dips a day with low risk is few and far between. A lot of what we manage is just our own
capital to take positions where we take an activist approach and where we will buy five to 15
percent of a company. It depends on their bylaws. If they have a poison pill, you want to look
at the shareholder profile. But based on all sorts of different inputs and analysis, if the company is
under the radar, you believe it's trading at a big discount to its private market value.
And that's not just your instinct, but because you've talked to a bunch of different industry
players and investment bankers, there's a bunch of private equity firms, for example, that would
love to buy a bunch of these small cap companies. And if all these companies were for sale,
I think talked to enough of them that they would drop everything and just focus on those
opportunities rather than trading assets to each other in the private market, you know,
doing their typical game of cut a cost and then trying to sell at the whatever.
they adjust to be badal looks like the highest but there's a lot of these niche little companies
that these private equity firms would like to own it they are not willing typically to take
positions in public companies certainly not willing to be activist they're always we call ourselves
friendly activists but if there's if you have boards and management teams that are not acting
in shareholders best interest because for whatever reason there's a bunch of the board members
or retirees they like saying they're on a public board they like the compensation from it but
they don't own any stock, they are not aligned with you, the shareholder that owns 9% of the company.
And so, you know, we will try to get board seats. We've gotten board seats on a number of different
companies. And ultimately, if they're too small to be public, too nichey, too hard to understand,
they're never, they're going to have to grow many multiples to become relevant and you kind of
get on someone's radar. They shouldn't be public. And if they're, is that what you're
typically doing? You're taking these public companies and you're selling them in private markets.
That is the goal in a lot of our activism. But, you know, a lot of
of the management teams and boards don't like that.
So we're open to all sorts of different alternatives.
A lot of them will want to divest something at a premium to the multiple that they're
training for a division or often we see a lot of them trying to make acquisitions to
grow into a bigger thing.
That comes with his own risk.
You take, let you leverage up to do that.
And it's a lot of what my partner and I like to call like Empire Builders where the board
is like, hey, let's do a roll up in the public markets.
If you've been considering futures trading now might be the time to take a closer look.
The futures markets has seen increased activities.
recently and Plus 500 futures offers a straightforward entry point. The platform provides access
to major instruments, including the S&P 500, NASDAQ, Bitcoin, natural gas, and other key markets
across equity indices, energy, metals, Forex, and crypto. Their interface is designed for accessibility.
You can monitor and execute trades from your phone with a $100 minimum deposit. Once your account is open,
potential trades can be executed in two clicks. For those who prefer to practice first,
Plus 500 offers an unlimited demo account with full charting and analytical tools.
No risk involved while you familiarize yourself with the platform.
The company has been operating in a trading space for over 20 years.
Download the Plus 500 app.
Trading and futures involves the risk of loss is not suitable for everyone.
Not all applicants will qualify.
Well, if you're a nichey little $100 million public company, for example,
I can say this because we're on file.
We've filed a 13D on a company called QuipT Home Medical.
that does, they're about a, about a $100 million market cap. They trade for four times I beta. They're
a provider of home health services specifically in the niche that is the respiratory space. So think
CPAP machines for sleep apnea, oxygen, most of it is respiratory related in-home sales and rental
and servicing around that. Well, they've made some acquisitions, but the stock, the stock
crisis, ultimately the scorecard is the stock price. And so, you know, in the short term,
it could be a voting machine, the long term, it could be a weighing machine.
But if it's been, if you're five for 10-year, 15-year IRA as a public company is really subpar.
You have more vulnerability.
There's an annual meeting in an election, and those companies, ultimately shareholders have certain rights.
You've got to look at the bylaws of the companies.
We've never, we haven't, we've typically settled with companies and gotten board members that way.
And when you have board members, you have more influence.
When I was on the board at Del Taco, because we were trading a big discount to private
market value. We got a number of different inbound bids, typically from private equity, some from
you know, large known quantities and some from funds that we've never heard of that you kind of
get to see how well funded are they, are they for real? Well, first, there's that arb of just if you
take away public company costs. And also, you're not focused on the next quarter, which public
companies are too focused on versus the next five years or whatever. I saw it firsthand. Like we were,
their LBO math suggested that, that, that, that they were going to get, they were going to be
able to pay a big premium to public market value, ticket private, and still make a good
IRA. That's them levering up typically and taking a lot of risk. In the case of Del Taco, we sold
it to Jack in the Box. The best buyer typically is a strategic because there's synergies versus
private equity. We sold to Jack and the Box is its own public company. We sold to them in
2022. They just, I believe the enterprise value on the deal was six or 700 billion. They just sold
it for the low one hundreds. There's been a whole bunch of things negatively affecting the
restaurant industry, fast food, GLP ones and things I could go on and on about. But,
and that was the risk that they took. How long does it take you to build a case to go
activist? How many conversations? Talk to me about that process. It depends on the company.
You know, we've just having been in the small cap markets for my whole career,
actually the more arbitrage-like things have been more for the last 15 years. But the full 25
years I've been in the public markets has been, I've always been picking stocks. So if you have some
historical knowledge of the companies.
We're finding companies through
screens, but a lot of it's just from having knowledge of
founding it, however we found it before.
You can talk to other fund managers or whatever.
You're trying to do as comprehensive of analysis as you can.
Now, there's limitations in that
there's quarterly public filings.
You don't always get full access.
You don't want inside information, of course.
Based on all those inputs and some instinct,
you think that the LBO model for that particular company
suggests that if you take away the $5 million
of public company costs,
and you make certain assumptions and the LBO model is only as good as its assumptions,
that's the private equity.
That's the scorecard for them for private equity.
It's like, and such an important metric for the LBO model is what are you going to sell
it for five years?
And you see so many models that just show consistent growth and then they sell it for a big
multiple five years out.
Well, there's plenty of uncertainty in that.
And a lot that can go wrong.
Certainly you could exceed it, but the average model is probably too aggressive.
And if you're trying to auction off a company, the highest bidder could have the most
aggressive model or the cheapest cost of funding or the most synergies, we want to know everything
we can.
And so we are not by no means experts on respiratory home health services and equipment.
We've learned as much as we can.
Importantly, in that case, just to continue with that example, there is a public bid.
It's been in a public press release from another investor that owns 9% of the company.
That's the largest shareholder.
I think the stock closed at $2.52 today, but has been.
traded way lower than that recently.
They have a non-contingent bid at $3.10.
So they want to buy the company.
They've said at $3.10, their best bid is $3.10.
It's not contingent on diligence or financing.
Of course, things could change.
That came out in a press release.
Could they back off of that?
Sure, there is risk.
Could they increase it?
Well, we think it's worth more than $3.10 cents to share because we think the cash flow,
forward cash flow, particularly when with, you know,
responsible leadership suggests that it's worth more than that, but it's going to take a
board to decide that they want to run a process. And so we're not sure. I mean, they had a
lawsuit, an active lawsuit against that buyer, and we think that's incredibly wasteful. There's no
known way that they're going to have to be forced to sell. Ultimately, there's an annual meeting
and shareholders get to vote just like, you know, a democratic election. We get to vote our eight or nine
percent of stock for for the directors that we want and then you know hopefully those directors will
do what's right for shareholders and and if if the best risk adjusted return is to run a sale process
and sell to the highest bidder that's that's what they ought to do but there's there's different
different ways to go at it and that's not always what we think in this in the case of this quipt home
medical though very small niche public company they've got some complicated accounting that makes
it harder for other people to roll their sleeves and fully understand it and so you know we think
the risk adjusted return is is is really good but a lot of these
companies are down and out. They weren't always microcap. They went there. And there's,
in this industry, there's reimbursement risk, insurance, government reimbursement. So, you know,
you got to just factor in all the different things and say, this is among the best risk adjusted
return. I can find it. I'm going to take an extra set position. What's one piece of timeless
advice that you wish you could go back and give yourself that would have significantly increased
the chance of success in your career and or decrease some of the risks?
One really interesting thing is we've seen so much technological advancement in the last couple decades,
such that growth has outperformed value.
And there have been other periods historically that have that's been the case.
But growth has outperformed value by a wide margin in the last 20 years.
And so, you know, if you read Intelligent Investor Benjamin Graham or you look at a lot of data,
There's some really good data from Eugene Fama and Kent,
Kenneth,
professors in Chicago and Dartmouth,
they would show,
and my mentor,
a guy by the name of David Heller,
we were very empirically focused looking at a lot of historical data.
Very, his philosophy was very deep value focused.
And so if you go back almost any decade
in the history of the markets before that,
the smaller, deeper value companies outperformed.
So if you just bought an index of those companies
that were among a certain peer group of small, small companies trading at the biggest discounts
to book value and then those the Fama French indices adjust every year, you would have outperformed.
So if you're trying to find just sort of edge in a bucket of companies to buy, history would
tell you to do that. Well, in the last 20 years, we've seen such incredible technological advancement
and, you know, industries like retail, I mentioned before, we've made a bad investment in big lots,
for example, you know, to be mindful of, more mindful of technological change, trying to understand
what that means for some of these value companies to avoid value traps. So, and if there's easier said
than done, but we've pivoted from very much deep value stock picking to more of a, there's a Joel
Greenblatt style of value investing where it's, it's those companies trading at the biggest discounts,
but also that generate the highest return on invested capital. And so, you know, we've gotten into different
companies, whether they were previously super profitable and became unprofitable, like big
lots or other, or just the slowly competed way, the dinosaurs, I've never invested in this
company, but Deluxe Corporation prints some huge market share of handwritten checks for people's
bank accounts. Well, I can't remember the last time I mean, I probably still write a check here
there if my assistant helps me with, but, you know, there's a world with technology where we've
made such technological advancements that the Amazon's of the world have made it very difficult
for almost every category of retail.
You can click a button from your home.
And so, you know, to just buy deep value companies
based on where they trade to book value
is an important lesson that I've learned.
All right, this has been an absolute masterclass.
Thanks so much for jumping on the podcast
and looking forward to continuous conversation live.
Thank you. Yeah, likewise.
Thank you.
Appreciate it very much.
That's it for today's episode of How I Invest.
If this conversation gave you new insights or ideas,
do me a quick favor.
Share with one person in your network
who'd find a valuable or leave a short.
short review wherever you listen. This helps more investors discover the show and keeps us bringing
you these conversations week after week. Thank you for your continued support.
